immuno-oncology Archives -

Scotland backs Cabometyx combo for kidney cancer, amid stalled NICE review

https://pharmaphorum.com/news/scotland-backs-cabometyx-combo-for-kidney-cancer-amid-stalled-nice-review/

FDA halts Allogene CAR-T trial after safety scare

https://pharmaphorum.com/news/fda-halts-allogene-car-t-trial-after-safety-scare/

J&J bulks up in bispecifics with $1.3bn Xencor alliance

https://pharmaphorum.com/news/jj-bulks-up-in-bispecifics-with-1-3bn-xencor-alliance/

3rd Inflammasome Therapeutics Summit

https://pharmaphorum.com/events/3rd-inflammasome-therapeutics-summit/

Kite claims a first for CAR-T Tecartus in adult leukaemia

https://pharmaphorum.com/news/kite-claims-a-first-for-car-t-tecartus-in-adult-leukaemia/

GSK bails on $4.2bn partnership with Merck on cancer drug

https://pharmaphorum.com/news/gsk-bails-on-4-2bn-partnership-with-merck-on-cancer-drug/

https://pharmaphorum.com/news/nice-clears-nhs-use-of-roches-tecentriq-in-bladder-cancer/

Keytruda’s liver cancer approval secured by new study

https://pharmaphorum.com/news/keytrudas-liver-cancer-approval-secured-by-new-study/

Boehringer buys Abexxa, bolstering its immuno-oncology pipeline

https://pharmaphorum.com/news/boehringer-buys-abexxa-bolstering-its-immuno-oncology-pipeline/

Search